参考文献/References:
［1］ Kanda T．Interferon-free treatment for HCV-infected patients w
ith decompensated cirrhosis［J］．Hepatol Int，2017，11(1)：38-44．
［2］ Welch NM，Jensen DM．Pegylated interferon based therapy with second-wave
direct-acting antivirals in genotype 1 chronic hepatitis C［J］．Liver Int，20
15，35(Suppl 1)：11-17．
［3］ Coppola N，De Pascalis S，Onorato L，et al．Hepatitis B virus and hepatit
is C virus infection in healthcare workers［J］．World J Hepatol，2016，8(5)：27
3-281．
［4］ Flisiak R，Pogorzelska J，Flisiak-Jackiewicz M．He-patitis C：efficacy
and safety in real life［J］．Liver Int，2017，37(Suppl 1)：26-32．
［5］ 王方平，张平安，牛志立．固有免疫和适应性免疫与慢性丙肝的研究进展［J］．现
代检验医学杂志，2015，30(6)：6-9．
Wang FP，Zhang PA，Niu ZL．Studies about innate and adaptive immune
responses on chronic hepatitis C［J］．Journal of Modern Laboratory Medicine，20
15，30(6)：6-9．
［6］ Oshiumi H，Matsumoto M，Seya T．Innate immune res-ponses against viral i
nfection and its suppression by viral proteins［J］．Yakugaku Zasshi，2013，133(
3)：323-328．
［7］ Oshiumi H，Matsumoto M，Seya T．Innate immune response to RNA virus infec
tion［J］．Uirusu，2011，61(2)：153-161．
［8］ Oshiumi H，Funami K，Aly HH,et al．Multi-step regulation of interferon i
nduction by hepatitis C virus［J］．Arch Immunol Ther Exp (Warsz)，2013，61(2)：
127-138．
［9］ Liu Y，Goulet ML，Sze A,et al．RIG-I-Mediated STING upregulation restri
cts herpes simplex virus 1 infection［J］．J Virol，2016，90(20)：9406-9419．〖
ZK)〗
［10］ Cheng Y，Sun Y，Wang H,et al．Chicken STING mediates activation
of the IFN gene independently of the RIG-I gene［J］．J Immunol，2015，195(8)：
3922-3936．
［11］ 中华医学会肝病学分会，中华医学会感染病学分会．丙型肝炎防治指南(2015年更
新版)［J］．中华实验和临床感染病杂志(电子版)，2015，9(5)：590-607．
Chinese Society of Hepatology and Chinese Society of Infectious Diseases，
Chinese Medical Association．The guideline of prevention and treatment for chron
ic hepatitis C(2015 update)［J］．Chinese Journal of Experimental and Clinical I
nfectious Diseases(Electronic Edition)，2015，9(5)：590-607．
［12］ Pfaffl MW．A new mathematical model for relative quantification in real
-time RT-PCR［J/OL］．Nucleic Acids Res，2001，29(9)：e45．
［13］ Livak KJ，Schmittgen TD．Analysis of relative gene expression data usin
g real-time quantitative PCR and the 2-Delta Delta C (T)method［J］．Methods，
2001，25(4)：402-408．
［14］ Konno H，Barber GN．The STING controlled cytosolic-DNA activated innate
immune pathway and microbial disease［J］．Microbes Infect，2014，16(12)：998-
1001．
［15］ Ran Y，Shu HB，Wang YY．MITA/STING：a central and multifaceted mediator
in innate immune response［J］．Cytokine Growth Factor Rev，2014，25(6)：631-63
9．
［16］ Liu S，Cai X，Wu J，et al．Phosphorylation of innate immune adaptor prot
eins MAVS，STING and TRIF induces IRF3 activation［J］．Science，2015，347(6227)
：aaa 2630．
［17］ Atianand MK，Fitzgerald KA．Molecular basis of D-NA recognition in the
immune system［J］．J Immunol，2013，190(5)：1911-1918．
［18］ Cao X，Ding Q，Lu J，et al．MDA5 plays a critical ro-le in interferon r
esponse during hepatitis C virus infection［J］．J Hepatol，2015，62(4)：771-77
8．
［19］ Biacchesi S，Mérour E，Lamoureux A,et al．Both ST-ING and MAVS fish or
thologs contribute to the induction of interferon mediated by RIG-I［J］．PLoS
One，2012，7(10)：e47737．
［20］ Carroll EC，Jin L，Mori A,et al．The vaccine adjuvant chitosan promotes
cellular immunity via DNA sensor cGAS-STING-Dependent induction of type I inte
rferons［J］．Immunity，2016，44(3)：597-608．
［21］ Yang D，Liu N，Zuo C,et al．Innate host response in primary human hepato
cytes with hepatitis C virus infection［J］．PLoS One，2011，6(11)：e27552．
［22］ Zevini A，Olagnier D，Hiscott J．Crosstalk between cytoplasmic RIG-I an
d STING sensing pathways［J］．Trends Immunol，2017，38(3)：194-205．
［23］ Welsch C，Haselow K，Gouttenoire J，et al．Hepatitis C virus variants re
sistant to macrocyclic NS3-4A inhibitors subvert IFN-β-induction by efficien
t MAVS cleavage［J］.J Hepatol，2015，62(4)：779-784．
［24］ Parera M，Martrus G，Franco S，et al．Canine hepacivirus NS3 serine prot
ease can cleave the human adaptor proteins MAVS and TRIF［J/OL］．PLoS One，2012
，7(8)：e42481．
相似文献/References:
[1]邓刚,张平安.慢性丙型肝炎男性患者体内雌雄激素与抗黏病毒基因表达的关系[J].现代检验医学杂志,2015,30(05):53.[doi:10.3969/j.issn.1671-7414.2015.05.016]
DENG Gang,ZHANG Ping-an.Role of Estrogen and Androgen on Gene Expression of Myxovirus
Resistance A in Male Patients with Chronic Hepatitis C[J].Journal of Modern Laboratory Medicine,2015,30(03):53.[doi:10.3969/j.issn.1671-7414.2015.05.016]
[2]王方平,张平安,牛志立.固有免疫和适应性免疫与慢性丙肝的研究进展[J].现代检验医学杂志,2015,30(06):6.[doi:10.3969/j.issn.1671-7414.2015.06.002]
WANG Fang-ping,ZHANG Ping-an,NIU Zhi-li.Studies about Innate and Adaptive Immune
Responses on Chronic Hepatitis C[J].Journal of Modern Laboratory Medicine,2015,30(03):6.[doi:10.3969/j.issn.1671-7414.2015.06.002]
[3]牛志立,张平安,童永清.探讨性别和年龄在慢性丙型肝炎患者
外周血Toll样受体3和7基因表达中的影响[J].现代检验医学杂志,2015,30(01):23.[doi:10.3969/j.issn.1671-7414.2015.01.007]
NIU Zhi-li,ZHANG Ping-an,TONG Yong-qing.Exploring Impact of Gender and Age Discrepancies
on the Expression of Toll-like Receptor 3 and 7 Gene mRNA
of Patients with Chronic Hepatitis C Infection[J].Journal of Modern Laboratory Medicine,2015,30(03):23.[doi:10.3969/j.issn.1671-7414.2015.01.007]
[4]吴志美,袁建芬,徐 建,等.慢性丙型肝炎患者外周血CD3+CD16+56+NK细胞水平与肝纤维化指标相关性分析[J].现代检验医学杂志,2018,33(04):95.[doi:10.3969/j.issn.1671-7414.2018.04.025]
WU Zhi-mei,YUAN Jian-fen,XU Jian,et al.Correlation Analysis of CD3+CD(16+56)+NK Cell Level in Peripheral
Blood and Liver Fibrosis Index in Patients with Chronic Hepatitis C[J].Journal of Modern Laboratory Medicine,2018,33(03):95.[doi:10.3969/j.issn.1671-7414.2018.04.025]
[5]欧阳清慧,王 冰,杨自力,等.四川省绵阳地区慢性丙型肝炎患者继发2 型糖尿病危险因素分析[J].现代检验医学杂志,2020,35(04):151.[doi:10.3969/j.issn.1671-7414.2020.04.038]
OUYANG Qing-hui,WANG Bing,YANG Zi-li,et al.Analysis of Risk factors of Chronic Hepatitis C Complicated with Type 2 Diabetes Mellitus in Mianyang of Sichuan[J].Journal of Modern Laboratory Medicine,2020,35(03):151.[doi:10.3969/j.issn.1671-7414.2020.04.038]